Compare NATL & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NATL | PBH |
|---|---|---|
| Founded | 2023 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.9B |
| IPO Year | N/A | 2005 |
| Metric | NATL | PBH |
|---|---|---|
| Price | $40.17 | $66.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $42.75 | ★ $85.40 |
| AVG Volume (30 Days) | 351.2K | ★ 406.5K |
| Earning Date | 02-26-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 1.74 | ★ 3.79 |
| Revenue | ★ $4,322,000,000.00 | $1,103,606,000.00 |
| Revenue This Year | $2.83 | N/A |
| Revenue Next Year | $3.96 | $2.24 |
| P/E Ratio | $23.08 | ★ $17.50 |
| Revenue Growth | ★ 0.63 | N/A |
| 52 Week Low | $22.30 | $57.25 |
| 52 Week High | $42.23 | $90.04 |
| Indicator | NATL | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 56.72 | 52.57 |
| Support Level | $35.94 | $63.69 |
| Resistance Level | $39.51 | $68.62 |
| Average True Range (ATR) | 1.33 | 2.10 |
| MACD | 0.11 | -0.09 |
| Stochastic Oscillator | 93.22 | 39.98 |
NCR Atleos Corp is financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. Atleos manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications abd Technology.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.